What are the diagnostic criteria for acute kidney injury (AKI)?

Diagnostic Criteria for Acute Kidney Injury

Acute kidney injury is diagnosed when any one of the following three criteria is met: serum creatinine rises by ≥0.3 mg/dL within 48 hours, OR serum creatinine increases to ≥1.5 times baseline within 7 days, OR urine output falls below 0.5 mL/kg/h for more than 6 consecutive hours. 1, 2

Core KDIGO Diagnostic Criteria

The three diagnostic criteria operate independently—meeting any single criterion establishes the diagnosis: 1, 3

• Absolute creatinine rise: Increase of ≥0.3 mg/dL (≥26.5 µmol/L) within any 48-hour window 1, 2
• Relative creatinine rise: Increase to ≥1.5 times the baseline value within the preceding 7 days 1, 3
• Oliguria criterion: Urine output <0.5 mL/kg/h sustained for ≥6 consecutive hours 1, 2

Even the modest 0.3 mg/dL threshold is clinically significant—it independently associates with approximately a 4-fold increase in hospital mortality. 1, 4

Establishing Baseline Creatinine

Use the most recent serum creatinine measured within the prior 3 months, selecting the value closest to hospital admission. 1, 2 This approach is superior to imputation methods. 1

• If no prior measurement exists, the admission creatinine serves as baseline 1, 2
• Do not back-calculate baseline creatinine using MDRD equations in patients with cirrhosis—this method is explicitly excluded for this population 1, 2
• Back-calculating an assumed eGFR of 75 mL/min/1.73 m² overestimates AKI incidence in populations with high CKD prevalence 1

KDIGO Staging System

Stage AKI by the most severe criterion met (creatinine or urine output): 1, 2

Stage	Creatinine Criterion	Urine Output Criterion
Stage 1	1.5–1.9× baseline OR rise ≥0.3 mg/dL	<0.5 mL/kg/h for 6–12 hours
Stage 2	2.0–2.9× baseline	<0.5 mL/kg/h for ≥12 hours
Stage 3	≥3.0× baseline OR ≥4.0 mg/dL (with acute rise ≥0.3 mg/dL) OR initiation of dialysis	<0.3 mL/kg/h for ≥24 hours OR anuria ≥12 hours

Higher stages correlate with progressively greater mortality risk. 1, 4

Special Considerations for Cirrhotic Patients

In patients with cirrhosis and ascites, focus exclusively on serum creatinine changes—urine output criteria are unreliable. 1, 2

• These patients are frequently oliguric with avid sodium retention yet maintain relatively normal GFR 5, 1
• Diuretic therapy further confounds urine output interpretation 1, 2
• Volume expansion from ascites dilutes serum creatinine, lowering its concentration independent of true kidney function 1, 2
• A creatinine threshold of ≥1.5 mg/dL predicts AKI progression and worse prognosis in cirrhosis 1

Common Pitfalls and Confounders

Relying solely on serum creatinine without considering urine output may miss cases of AKI, but in specific populations urine output is misleading. 1

Factors That Mask True Creatinine Rise:

• Massive fluid resuscitation dilutes serum creatinine, potentially hiding significant GFR reduction 5, 1
• When cumulative fluid gain exceeds 5–10% of baseline body weight, measured creatinine should be corrected for volume expansion 1
• Patients with reduced muscle mass (elderly, females, malnutrition, critical illness) have lower baseline creatinine, blunting the apparent rise during AKI 1

Laboratory Interferences:

• Hyperbilirubinemia causes false elevation with Jaffe assays and false reduction with enzymatic assays 1, 2
• Medications that inhibit tubular secretion (trimethoprim, cimetidine) produce spuriously high creatinine values 1

When Urine Output Is Unreliable:

• Patients receiving diuretics 1, 2
• Cirrhosis with ascites 1, 2
• Urine collection inaccuracies influenced by body weight, race, age, gender 1

Monitoring and Follow-Up

• Serial monitoring of serum creatinine and urine output is required after diagnosis to determine stage and track progression 1, 2
• All patients should be re-evaluated at 3 months post-AKI to assess for resolution, new-onset CKD, or progression of pre-existing kidney disease 1
• Even patients without prior CKD who experience AKI have elevated risk of subsequent kidney dysfunction 1

Acute Kidney Disease (AKD) Framework

When kidney dysfunction persists 7–90 days after onset, classify as Acute Kidney Disease (AKD): 1

• AKI represents the acute phase (≤7 days) 1
• AKD captures the subacute recovery or progression phase (7–90 days) 1
• Dysfunction lasting >90 days is defined as chronic kidney disease 1
• AKD can occur with or without preceding AKI 1

When to Consult Nephrology

Stage 2 or Stage 3 AKI warrants prompt nephrology involvement. 1